Sharing Life Sciences Innovations

Join our 20.000 subscribers and receive the newsletter for free!

Upcoming events

NLO Seminar 'Innovation & IP Strategy"

Ghent
Thu 19 Jan 2017
14:00

On Thursday 19 January 2017, NLO, European patent and trademark attorneys, is organising a seminar in Ghent about ‘Innovation & IP Strategy’ to start the new year well. This will be an inform…

Read more

ER Stress, Autophagy & Immune System

Sint-Janshospitaal, Mariastraat 38, 8000 Brugge
Thu 26 Jan 2017 - Fri 27 Jan 2017
26 Jan 09:00 - 27 Jan 17:00

ER stress and autophagy are evolutionary conserved cellular pathways that play important roles in our defense against proteotoxic stress and infections.  They are likely to be major pathways…

Read more

Innovation for Health

WTC Rotterdam
Thu 16 Feb 2017
09:30

After three editions, Innovation for Health is considered the largest and leading conference in the Netherlands for Health and Life Sciences innovators. This is the place where key player…

Read more

V-Bio feature: Mosquito Wars

V-Bio feature: Mosquito Wars

Mosquitoes are carriers of a range of crippling diseases, posing an enormous global health burden. Because current methods based on insecticides are inadequate, new tools are urgently needed. Wide…

Read more

MDx Health ConfirMDx test covered by new insurance group

MDxHealth Announces Horizon Blue Cross Blue Shield of New Jersey Issues Positive Coverage Policy on ConfirmMDx. The decision provides access to more than 3.8 million members.

Read more

Medulloblastoma orphan drug designation for Oncurious

Oncurious, an emerging oncology company focused on the development of innovative orphan drugs for the treatment of pediatric tumors, announces that the European Commission has confirmed the orphan…

Read more

Market Access – the pitfall where innovations go lost

Market Access – the pitfall where innovations go lost

Market access is a crucial turning point for many companies. Getting your drug reimbursed by the government means the world. However, gaining market access is a difficult and elaborate process tha…

Read more

Better together: R&D and GMP analytics teamed up at anaRIC Biologics

Better together: R&D and GMP analytics teamed up at anaRIC Biologics

Biologics are conquering the medical space. The need for high-quality analytical service companies for biological products has never been bigger. Unfortunately, fragmentation of expertise is a pro…

Read more

Coris Bioconcept diagnoses antibiotic resistance

Coris Bioconcept diagnoses antibiotic resistance

With almost 20 years of experience, Coris BioConcept knows the world of infectious disease diagnostics inside and out. Their straightforward chromatography-based assays for pathogen detection, whi…

Read more

Legislators finally embrace in silico trials

Legislators finally embrace in silico trials

In silico analysis is a natural complement to in vivo and in vitro testing. It uses engineering simulation to create reliable, computer-based models that predict interactions among medical devices…

Read more

PharmaFluidics raises 2.7 million euro to commercialize novel micro-chip device

PharmaFluidics NV, a game-changing innovator in the field of analytical chromatography, announced today that it has raised 2.7 million euro of additional funding.

Read more

IP strategy for oligonucleotides

IP strategy for oligonucleotides

Oligonucleotides have been gaining traction in the world of molecular biology. Their huge potential in both diagnostic and therapeutic applications has made them a popular research subject. Howeve…

Read more

Flanders Innovation and Enterpreneurship hands out over 500 million euros

Flanders Innovation and Enterpreneurship hands out over 500 million euros

Startup companies can get funding from the Flemish government for their R&D activities. Recently, the responsible agency was reformed and is now known as Flanders Innovation and Enterpreneurship (…

Read more

V-Bio Ventures spends big money in life sciences

V-Bio Ventures spends big money in life sciences

Only one year after its inception, the life science investment fund V-Bio Ventures made its first investments in three companies and announced the final closing of their first fund. Time to discus…

Read more

Confo Therapeutics: Drugging the Undruggable

Confo Therapeutics: Drugging the Undruggable

Llama single-domain antibodies have found yet another application, one that Confo Therapeutics is fully exploiting. Ablynx is developing Nanobodies®, AgroSavfe focuses on Agrobodies®, and Confo wi…

Read more

Join our 20.000 subscribers and receive the newsletter for free!

Upcoming events

NLO Seminar 'Innovation & IP Strategy"

Ghent
Thu 19 Jan 2017
14:00

On Thursday 19 January 2017, NLO, European patent and trademark attorneys, is organising a seminar in Ghent about ‘Innovation & IP Strategy’ to start the new year well. This will be an inform…

Read more

ER Stress, Autophagy & Immune System

Sint-Janshospitaal, Mariastraat 38, 8000 Brugge
Thu 26 Jan 2017 - Fri 27 Jan 2017
26 Jan 09:00 - 27 Jan 17:00

ER stress and autophagy are evolutionary conserved cellular pathways that play important roles in our defense against proteotoxic stress and infections.  They are likely to be major pathways…

Read more

Innovation for Health

WTC Rotterdam
Thu 16 Feb 2017
09:30

After three editions, Innovation for Health is considered the largest and leading conference in the Netherlands for Health and Life Sciences innovators. This is the place where key player…

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Biowin NLO Bridge 2 Health UGent Turnstone Janssen FlandersBio GSK V-Bio Ventures KU Leuven Lifetech.brussels VIB

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.